SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 67 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $243,000 | -34.0% | 25,000 | 0.0% | 0.01% | -57.1% |
Q3 2017 | $368,000 | -49.7% | 25,000 | -45.1% | 0.01% | -54.8% |
Q2 2017 | $732,000 | +14.9% | 45,500 | +13.8% | 0.03% | +24.0% |
Q1 2017 | $637,000 | +6.9% | 40,000 | -18.4% | 0.02% | -13.8% |
Q4 2016 | $596,000 | -12.4% | 49,000 | 0.0% | 0.03% | -31.0% |
Q3 2016 | $680,000 | -18.3% | 49,000 | +6.9% | 0.04% | -34.4% |
Q2 2016 | $832,000 | – | 45,857 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |